大悦城地产(00207.HK)16.4亿人币投得海南三亚地块 拟发展多用途综合体及服务型公寓
大悦城地产(00207.HK)公布,间接附属公司三亚嘉悦已接获确认书,批准其以16.39亿元人民币(下同)竞得位於中国海南省三亚市的地块,总地盘面积约6.33万平方米,拟定用於商用及服务式公寓。
公司预期将於2019年12月24日或之前签订有关收购事项的土地使用权出让合同。三亚嘉悦已支付一笔共9.83亿元的款项作为拍卖会的保证金。紧随收购事项完成後,公司将间接於该地块中拥有权益。
公司指,鉴於该地块的位置及指定用途,预计将用於大悦城城市多用途综合体及服务型公寓的开发,旨在於该地块开发完成後实现高投资价值,从而为集团带来稳定的收入及利润。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.